Contract 75A50123C00039

Eradivir Inc · Department Of Health And Human Services · September 18, 2023

Firm Fixed PriceFull & Open CompetitionNAICS 541714

Eradivir Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 18, 2023 for $749,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Collegeville, PA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 10, 2024.

Obligated to date
$749.2K
$749,165
Current value
$749.2K
Modifications
3
Latest September 10, 2024

Contract details

PIID
75A50123C00039
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
Health R&D Services; Health Care Services; Experimental Development
Place of performance
Collegeville, PA
First action
September 18, 2023
Latest action
September 10, 2024

Description

ERADIVIR INC. IND STUDIES IS TO COMPLETE A PACKAGE OF GLP-COMPLIANT NONCLINICAL SAFETY STUDIES THAT WILL SUPPORT A SUCCESSFUL INITIAL IND APPLICATION

Modification timeline

  • September 10, 2024
    Mod P00003
    $0
  • April 25, 2024
    Mod P00002
    $0
  • February 14, 2024
    Mod P00001
    $0
  • September 18, 2023
    Base award
    $749.2K

Similar contracts

RecipientAgencyDateObligated
Vericel CorporationDepartment Of Health And Human ServicesApril 1, 2026$34.88M
Ceramedix Holding, LlcDepartment Of Health And Human ServicesMarch 31, 2026$4.22M
American College Of Medical Toxicology, Inc.Department Of Health And Human ServicesMarch 31, 2026$0
Glaxosmithkline, LlcDepartment Of Health And Human ServicesMarch 31, 2026$7.79M
Care Access Research LlcDepartment Of Health And Human ServicesMarch 31, 2026$2.55M
Pattern Bioscience, Inc.Department Of Health And Human ServicesMarch 31, 2026$22.50M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50123C00039?

Contract 75A50123C00039 is a federal contract awarded to Eradivir Inc by Department Of Health And Human Services on September 18, 2023 for $749,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.

Who won contract 75A50123C00039?

Eradivir Inc won contract 75A50123C00039 from Department Of Health And Human Services.

How much is contract 75A50123C00039 worth?

Contract 75A50123C00039 has obligated $749,000 to date.